SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001587221-20-000024
Filing Date
2020-08-06
Accepted
2020-08-06 08:20:10
Documents
15
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zsan-20200806.htm   iXBRL 8-K 48388
2 EX-99.1 q220exhibit991ng.htm EX-99.1 152460
  Complete submission text file 0001587221-20-000024.txt   357562

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20200806.xsd EX-101.SCH 2435
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20200806_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20200806_def.xml EX-101.DEF 1651
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20200806_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20200806_pre.xml EX-101.PRE 13195
8 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20200806_htm.xml XML 11322
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 201079953
SIC: 2834 Pharmaceutical Preparations